application of (2-chloro-5-iodophenyl)(4-fluorophenyl)methanone_kain industrial additive
background and overview[1][2] (2-chloro-5-iodophenyl)(4-fluorophenyl)methanone is an intermediate in the synthesis of empagliflozin. empagliflozin is a type 2 sodium-glucose cotransporter inhibitor jointly developed by boehringer ingelheim and eli lilly and company. sglt-2 inhibitor is a new type of hypoglycemic drug. it mainly inhibits sglt-2 expressed in the kidney, reduces renal glucose reabsorption, increases the excretion of…

